[ad_1]
NEW YORK (Reuters Health) – Taking a well-known pain reliever increases the chances of survival of certain types of cancer, according to a recent study by researchers at the University of California at San Francisco.
The study found that painkillers such as aspirin or ibuprofen increased the chances of survival of a malignant disease by 25 to 78%, but only in patients with cancer-endowed of the modified gene called PIK3CA, a mutation carried by a third of tumors of the head and neck.
The study involved 266 patients with head and neck cancer at the University of Pittsburgh Medical Center in Pennsylvania, 75 of whom were pregnant.
Researchers looked at five-year survival rates of people with the disease and found that regular use of aspirin and prophylaxis increased those proportions, while warning that it was safe for people to get sick. was acting as a preliminary result that needed to be replicated as part of a clinical trial.
[ad_2]
Source link
